已收盤 10-24 16:00:00 美东时间
+0.250
+0.82%
Marex Group (NASDAQ:MRX) has agreed to acquire Valcourt SA, a fixed-income market maker based in Geneva, Switzerland. The deal is subject to regulatory approval and is expected to close in the first h...
10-22 19:14
Marex Group plc ((‘Marex' or the ‘Group', NASDAQ:MRX), the diversified global financial services platform, today announces that it has agreed to acquire Valcourt SA ("Valcourt").Valcourt is a fixed income market maker
10-22 19:04
Marex Group has agreed to acquire Valcourt SA, a fixed income market maker in Geneva. The deal will add 700 clients, strengthen Marex’s fixed income business, and expand its distribution offering in Switzerland. The acquisition reflects Marex’s strategy to diversify earnings and capabilities. Regulatory approval is required, with completion expected in early 2026. Both companies’ CEOs expressed excitement about the partnership and the potential t...
10-22 11:00
Marex Group plc executives and board members have purchased additional ordinary shares in the company, underscoring their confidence in its future growth. CEO Ian Lowitt and other top executives have increased their holdings, with the leadership team collectively owning more than 7% of the company. This move reflects their strong belief in Marex's prospects despite various risk factors outlined in the press release.
10-15 12:15
Ian Lowitt, chief executive officer of Marex Group(NASDAQ:MRX), purchased 32,465 ordinary shares in the open market on Friday, October 10. The transaction increases his total shareholding to 2.62M ord...
10-13 19:30
随着金融服务公司持续扩大全球业务布局以争夺更大市场份额,从道富银行到Marex Group等多家金融机构正积极拓展外包交易业务。
10-13 16:35
NEW YORK, Oct. 13, 2025 - Marex Group plc (“Marex”; NASDAQ: MRX), a global financial services platform, announced that its CEO Ian Lowitt purchased 32,465 ordinary shares, increasing his total holding to 2,615,016 shares. Marex offers services including clearing, agency and execution, market making, and hedging solutions, with access to 60 exchanges and over 40 offices worldwide.
10-13 11:00
今日重点评级关注:富国银行:维持Kyverna Therapeutics"超配"评级,目标价从24美元升至27美元;Chardan Capital:维持Oculis Holding"买入"评级,目标价从33美元升至51美元
10-09 10:51
Barclays analyst Benjamin Budish maintains Marex Group (NASDAQ:MRX) with a Overweight and lowers the price target from $50 to $40.
10-08 23:39